bromodeoxyuridine has been researched along with ap20187 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clayton, B; Fenstermaker, AG; Harding, HP; Jamison, S; Li, J; Lin, W; Lin, Y; Popko, B; Ron, D; Way, SW | 1 |
1 other study(ies) available for bromodeoxyuridine and ap20187
Article | Year |
---|---|
Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis.
Topics: Age Factors; Animals; Animals, Newborn; Brain; Bromodeoxyuridine; Cell Proliferation; Cells, Cultured; Cytokines; Disease Models, Animal; eIF-2 Kinase; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression Regulation; Immunosuppressive Agents; In Situ Nick-End Labeling; Mice; Mice, Transgenic; Microscopy, Electron, Transmission; Myelin Basic Protein; Myelin Proteolipid Protein; Neutrophil Infiltration; Oligodendroglia; Protein Phosphatase 1; Receptor Protein-Tyrosine Kinases; RNA, Messenger; Signal Transduction; Stem Cells; T-Lymphocytes; Tacrolimus; Time Factors; Transcription Factor CHOP | 2013 |